Literature DB >> 2919439

Malignant oncocytic carcinoid of the pancreas.

P H Carstens1, F K Cressman.   

Abstract

We report a rare case of malignant oncocytic carcinoid of the pancreas including the diagnostic immunocytochemical and electron microscopic findings. In addition the tumor shows some unusual ultrastructural features: lamelliform cristae and cytoplasmic and nuclear crystalline structures.

Entities:  

Mesh：

Year:  1989        PMID： 2919439     DOI： 10.3109/01913128909051162

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN： 0191-3123            Impact factor:   1.094


  5 in total

Review 1.  Carcinoid tumors of the pancreas. Status report based on two cases and review of the world's literature.

Authors:  C Mao; A el Attar; D R Domenico; K Kim; J M Howard
Journal:  Int J Pancreatol       Date:  1998-04

2.  Insulinoma-associated protein 1 (INSM1) is a useful marker for pancreatic neuroendocrine tumor.

Authors:  Masahiko Tanigawa; Masamichi Nakayama; Tomoki Taira; Satoshi Hattori; Yutaro Mihara; Reiichiro Kondo; Hironori Kusano; Ken Nakamura; Yushi Abe; Yusuke Ishida; Yoshinobu Okabe; Toru Hisaka; Koji Okuda; Kosuke Fujino; Takaaki Ito; Akihiko Kawahara; Yoshiki Naito; Rin Yamaguchi; Jun Akiba; Yoshito Akagi; Hirohisa Yano
Journal:  Med Mol Morphol       Date:  2017-08-28       Impact factor: 2.309

Review 3.  Pancreatic neuroendocrine neoplasms: Clinicopathological features and pathological staging.

Authors:  Alfred King-Yin Lam; Hirotaka Ishida
Journal:  Histol Histopathol       Date:  2020-12-11       Impact factor: 2.303

4.  Clinico-pathological features of a series of 11 oncocytic endocrine tumours of the pancreas.

Authors:  Marco Volante; Stefano La Rosa; Isabella Castellano; Giovanna Finzi; Carlo Capella; Gianni Bussolati
Journal:  Virchows Arch       Date:  2006-02-21       Impact factor: 4.064

Review 5.  Malignant pancreatic oncocytoma. An unusual cause of organic hypoglycemia.

Authors:  J L Sadoul; M C Saint-Paul; P Hoffman; M Plazza; Y Birtwisle; P Freychet; R Loubiere
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.